Peptide
N-Acetyl Semax
SaveAn N-acetylated form of semax designed for enhanced stability and bioavailability, with claimed nootropic and neuroprotective properties.
Quick verdict
Popular in the nootropics community as a more potent version of semax. Specific clinical data on this acetylated form are minimal.
Evidence score
A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.
What the research shows
Evidence is largely extrapolated from semax studies. Anecdotal reports suggest stronger nootropic effects than standard semax. No comparative clinical trials.
Benefits
- Enhanced stability over standard semax
- Nootropic effects inferred from semax literature
- Convenient intranasal administration
Dosage notes
Community protocols: 200–600 mcg intranasally daily. Not clinically validated.
Side effects
- Nasal irritation
- Headache
- Irritability at higher doses
Who should be cautious
Not approved in Western countries. Parent compound semax is approved only in Russia.
What this page cannot tell you
Comparative efficacy over standard semax is not clinically established.
Leaderboard scores
- Focus30
- Memory28
- Mood18
Write a review
Sign in to write a review.